Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Tuberculosis (TB) resistance to rifampicin, the most powerful drug leads to increase in mortality. Globally, half a million new patients develop such resistant TB each year, coupled with both inappropriate diagnosis and treatment initiation. We report a case of rifampicin resistant Mycobacterium tub...

Descripción completa

Detalles Bibliográficos
Autores principales: Ssengooba, Willy, Komakech, Kevin, Namiiro, Sharon, Byabajungu, Henry, Nalunjogi, Joanitah, Katagira, Winceslaus, Kimuli, Ivan, Joloba, Moses L, Adakun, Susan, Nakiyingi, Lydia, Torrea, Gabriela, Kirenga, Bruce J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592849/
https://www.ncbi.nlm.nih.gov/pubmed/34816021
http://dx.doi.org/10.1016/j.jctube.2021.100286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8592849/
https://www.ncbi.nlm.nih.gov/pubmed/34816021
http://dx.doi.org/10.1016/j.jctube.2021.100286

Ejemplares similares